Correlation Between BridgeBio Pharma and Cardiff Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BridgeBio Pharma and Cardiff Oncology, you can compare the effects of market volatilities on BridgeBio Pharma and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma and Cardiff Oncology.

Diversification Opportunities for BridgeBio Pharma and Cardiff Oncology

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between BridgeBio and Cardiff is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and BridgeBio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of BridgeBio Pharma i.e., BridgeBio Pharma and Cardiff Oncology go up and down completely randomly.

Pair Corralation between BridgeBio Pharma and Cardiff Oncology

Given the investment horizon of 90 days BridgeBio Pharma is expected to under-perform the Cardiff Oncology. But the stock apears to be less risky and, when comparing its historical volatility, BridgeBio Pharma is 1.64 times less risky than Cardiff Oncology. The stock trades about -0.04 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  211.00  in Cardiff Oncology on September 6, 2024 and sell it today you would earn a total of  30.00  from holding Cardiff Oncology or generate 14.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BridgeBio Pharma  vs.  Cardiff Oncology

 Performance 
       Timeline  
BridgeBio Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BridgeBio Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Cardiff Oncology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

BridgeBio Pharma and Cardiff Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BridgeBio Pharma and Cardiff Oncology

The main advantage of trading using opposite BridgeBio Pharma and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.
The idea behind BridgeBio Pharma and Cardiff Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing